Dana Blankenhorn

Rethinking Healthcare

Harvard study reopens Atkins controversy

By Dana Blankenhorn | Aug 25, 2009 |

A new study from a hospital associated with Harvard has reopened a controversy the widow of diet doctor Robert Atkins tried to end five years ago.

Beth Israel Deaconess researchers found a low carbohydrate, high protein diet (similar to the famous Atkins diet) led to a “significant increase in atherosclerosis” in mice, and “an impaired ability to form new blood vessels in tissues deprived of blood flow, as might occur during a heart attack.”

This happened despite the fact that cholesterol levels remained low and stable.

At its height in the 1990s the Atkins craze transformed eating in America, with dieters buying big steaks without potatoes. or bacon and eggs without toast, thinking they were doing themselves some good.

In 2004 Atkins’ widow Veronica issued a long statement denying that Atkins’ famous diet had anything to do with a heart condition discovered after his 2003 death from a head injury sustained when he fell on a sidewalk.

Atkins Nutritionals filed for bankruptcy in 2005, emerging in 2006 with a more balanced approach. Atkins’ first diet book, Dr. Atkin’s Diet Revolution, was published in 1972.

The Beth Israel Deaconess work seems to contradict a Harvard study published in 2006, following 20 years’ work, showing no link between heart disease and a low-carb diet. It did, however, suggest that vegetable fat and protein were better for the heart than animal sources.

A 2008 study at Tufts, meanwhile, indicated a link between low-carb diets and memory, a problem which disappeared once the diet was dropped.

In the press release on the latest Beth Israel study, authors Shi Yin Foo and Andrew Rosenzweig repeated the standard mantra, “a moderate and balanced diet, coupled with regular exercise,” but the mantra does not answer the key question of compliance.

Dieting remains hard. My advice? Buy smaller plates.

 
Reply to Story

SmartPlanet TalkbackShare your ideas and expertise on this topic

Subscribe to this discussion via RSS

  •  
    1

    larryswinford

    08/25/09 | Report as spam

    RE: Harvard study reopens Atkins controversy

    Let me guess, this was yet another study dependant upon the memories of test subjects concerning the foods, and their quantities. Unless a test group were sequestered and only allowed to eat controlled and defined quantities, both the test and control groups, we really don't have a solid idea about what does or does not honestly tend to affect this or that issue. Then too, the experiment has to be repeated and with substantial size and diversity of test subjects. Proving something with 20 lab rats and then 12 humans, or whatever their comparable numbers might have been, will not definitively establish the matter. Human chemistry, metabolic and more, is amazingly complex.

  •  
    2

    DanaBlankenhorn

    08/25/09 | Report as spam

    There are multiple studies here

    I may have confused you and I apologize for that. The most recent
    study is a mouse study. The 2006 study was a 20-year study of nurses'
    health.

    I agree that getting absolute answers from science is very hard. It's a
    process. Start with animal studies, then a few people, then more and
    more until we're satisfied as to efficacy, at which point the real test
    takes place in the market.

    Then there are longitudinal studies, usually based on surveys, like the
    Framingham Heart Study. Hopefully as health IT collects more data we
    can make such studies more accurate. Bigger numbers smooths out
    patterns.

  •  
    3

    jrg003

    08/25/09 | Report as spam

    RE: Harvard study reopens Atkins controversy

    Those things that God made in moderation.

The following tags are supported in Smartplanet comments:
<b></b> <i></i> <u></u> <pre></pre>

Leave a Reply

  1. Name: You are currently: a Guest |
advertisement

Quick Poll

advertisement

Dana Blankenhorn

Dana Blankenhorn has been a business journalist for nearly 25 years and has covered the online world professionally since 1985. He founded the Interactive Age Daily for CMP Media, and has written for the Chicago Tribune, Advertising Age's "NetMarketing" supplement, and dozens of other publications over the years.

Dana Blankenhorn

Dana Blankenhorn has been a technology reporter since 1982, a business reporter since 1978, and a writer for as long as he can remember. His Schwab IRA has a few tech stocks in it, most notably some Intel and Applied Materials bought over 10 years ago. But the vast majority of his tiny fortune (emphasis on the word tiny) is invested in mutual funds. He presently writes for no one else but ZDNet, SmartPlanet and himself. But if you've got an opportunity let him know. If he takes the gig he"ll first add it to this disclosure page.
Rethinking Healthcare examines innovation in the health care industry covering topics such as electronic and personal health records, treatment, privacy, regulation and using information technology to manage and monitor chronic conditions.